Dr V Shanta gets Padma Vibhushan; Padma Bhushan for Dr D Nageshwar Reddy

Monday, January 25, 2016

New Delhi: Cancer specialist Dr Vishwanathan Shanta has been selected for Padma Vibhushan, India’s second highest civilian award after Bharat Ratna, while gastroenterologist Dr D Nageshwar Reddy has been named for Padma Bhushan, the country’s third highest civilian award. They are among the 112 notable personalities to get Padma awards in 2016.

Dr V Shanta, chairman, Cancer Institute (WIA), Adyar, Chennai

Dr V Shanta, chairman, Cancer Institute (WIA), Adyar, Chennai

Cardiothoracic surgeons Dr Gopichand Mannam and Dr T K Lahiri; cardiac surgeon Dr Alla Gopala Krishna Gokhale; paediatric surgeons Dr Shiv Narain Kureel and Dr Nayudamma Yarlagadda; orthopaedic surgeon Dr John Ebnezar; and surgeon Dr Ravi Kant are among the notable doctors to get Padma Shri, the country’s fourth highest civilian award.

Other doctors who will get the Padma Shri awards announced by the government on Monday include Dr Praveen Chandra and Dr Daljeet Singh Gambhir (cardiology); Dr M V Padma Srivastava and Dr Sudhir V Shah (neurology); Dr Chandrasekar Seshadri Thoguluva (gastroenterology); Dr M M Joshi (ophthalmology); and Dr Sabyasachi Sarkar (radiology).

Dr H R Nagendra, Predrag K Nikic and Hui Lan Zhang (yoga); Dr Ram Harsh Singh (ayurveda); and Dr Anil Kumari Malhotra (homeopathy) have also been named among the winners of the Padma Shri award.

This year, President Pranab Mukherjee will confer 10 Padma Vibhushan, 19 Padma Bhushan and 83 Padma Shri awards on people from different walks of life. As many as 19 awardees are women and 10 are foreigners, non-resident Indians and People of Indian Origin (including one posthumous). Four of those on the honour list are posthumous awardees.

Categories: NEWS

Tags: , , , , , , , , , , , , , , , , , , , , ,

  More from NEWS

Indian pharmaceutical market to reach $56 billion in 2020

India’s ‘first women hospital’ inaugurated in Delhi

Ability to provide sight being shifted from corneal surgeries to newer technologies

Govt may reduce seats in surgical super-speciality courses that fail to attract doctors

New AI able to identify & predict development of cancer symptom clusters

Humira approved in Japan for treatment of Hidradenitis Suppurativa

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> in your comment.